Value and utility of structured self-monitoring of blood glucose in real world clinical practice: findings from a multinational observational study

Diabetes Technology & Therapeutics
Nebojsa LalicIldiko Amann-Zalan

Abstract

The Structured Testing Program (STeP) study, a cluster-randomized, controlled trial, showed that a structured self-monitoring of blood glucose (SMBG)-based intervention improves clinical outcomes. It is important to determine whether this intervention can be adapted for use in general medical practice. This study examined the feasibility and effects of a modified version of the STeP intervention on clinical and attitudinal outcomes in real world clinical settings. In this 3-month, observational, multinational study, 375 type 1 and type 2 diabetes patients in 11 countries were asked to generate a blood glucose (bG) profile once per month for 3 consecutive months, using a paper-based bG analysis tool (Accu-Chek® 360° View® bG analysis system, Roche Diagnostics, Mannheim, Germany). Measurements were to be performed before and 2 h after main meals and before bedtime on 3 consecutive days. End points included change from baseline in glycated hemoglobin (HbA1c) and other parameters of diabetes complications. Patient and physician attitudes toward use of the structured testing form were also assessed. Reductions in mean (SD) HbA1c from baseline were significant, from 9.2% (1.6%) to 8.0% (1.4%) (Δ -1.2% [1.6%], P<0.001). Reductions in ...Continue Reading

References

Nov 15, 2006·The Diabetes Educator·Mary M AustinM Teresa Volpone
Mar 16, 2007·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Shefali MaheshJose Bernardo Q Quintos

❮ Previous
Next ❯

Citations

Sep 28, 2013·Current Diabetes Reports·Daniel J CoxWilliam S Yancy
Jan 20, 2015·Current Medical Research and Opinion·Karin LangeThomas Haak
Apr 17, 2012·Diabetes Research and Clinical Practice·Antonio Ceriello
Apr 3, 2012·Diabetes Research and Clinical Practice·Christopher G ParkinMatthias Axel-Schweitzer
Aug 1, 2015·Journal of Diabetes Science and Technology·Joerg WeissmannIldiko Amann-Zalan
May 31, 2014·Journal of Diabetes Science and Technology·Deborah A GreenwoodCharlene C Quinn
Nov 20, 2013·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Gillian S Boyd-WoschinkoRonald Tamler
Dec 20, 2013·Journal of Diabetes Science and Technology·Pratik ChoudharyGérard Reach
Oct 27, 2015·Diabetes Technology & Therapeutics·Christopher G ParkinRolf Hinzmann

❮ Previous
Next ❯

Software Mentioned

Chek
Accu

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.